Guarding the Healing Pancreas: Supportive Role of Octreotide and Omeprazole

Background: Postoperative pancreatic complications such as pancreatic fistula, hyperamylasemia, and stress-related mucosal injury are significant concerns following pancreatic surgeries. Pharmacological agents like octreotide and omeprazole have been suggested to play a preventative role by inhibiting pancreatic secretion and gastric acid production, respectively.  Objective: The goal of this study was to check how well octreotide and omeprazole, either alone or together, work in preventing problems in the pancreas after surgery in patients who had planned surgery on their pancreas.  Methods: A study was done on 60 patients who were having planned surgery on their pancreas. The patients were split into three groups: one group got octreotide only, another got omeprazole only, and the third group got both medicines together. We kept track of several things that happened after the surgery, like how often complications such as pancreatic fistula, high amylase levels, stress ulcers, and the length of hospital stay occurred. Blood tests were done at 24, 48, 72 hours after the surgery to check levels of amylase in the blood.  Results: The group that received both medicines together had much fewer cases of pancreatic fistula and high amylase levels compared to the groups that received only one medicine. Octreotide and omeprazole individually showed modest effectiveness, but when used together, they significantly reduced postoperative enzyme levels and complication rates (p < 0.05). No significant adverse effects were noted in any group.  Conclusion: The combination of octreotide and omeprazole offers a synergistic effect in minimizing postoperative pancreatic complications. Integration of both agents into perioperative care protocols can improve surgical outcomes and reduce patient morbidity following pancreatic procedures.